These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5074965)

  • 1. [Clinical experience with a new postganglionie blockader (Debriosquin, R0-5-3307)].
    Ocon Pujadas J
    Rev Clin Esp; 1972 Jun; 125(6):521-32. PubMed ID: 5074965
    [No Abstract]   [Full Text] [Related]  

  • 2. Aliskiren for hypertension: just another option or something truly unique?
    Lee S
    S D Med; 2007 Oct; 60(10):405-6. PubMed ID: 18019776
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term treatment of hypertension with debrisoquin sulfate].
    Hammarström S
    Lakartidningen; 1970 Jun; 67(23):2663-8. PubMed ID: 5450560
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with a new antihypertensive agent].
    Stampfer E
    Wien Klin Wochenschr; 1971 Jan; 83(4):66-9. PubMed ID: 4994618
    [No Abstract]   [Full Text] [Related]  

  • 5. Debrisoquin sulfate: a clinical evaluation of a new antihypertensive agent.
    Blechman M; Sokol C; Moser M
    Curr Ther Res Clin Exp; 1969 Feb; 11(2):71-6. PubMed ID: 4975816
    [No Abstract]   [Full Text] [Related]  

  • 6. [Longterm treatment with a new antihypertensive agent].
    Wolkerstorfer H
    Wien Med Wochenschr; 1969 Jun; 119(25):502-4. PubMed ID: 5802413
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experience report on the combination antihypertensive agents DCR 1015 and DCR 515].
    Obrowsky L; Kern H
    Wien Med Wochenschr; 1969 Jan; 119(2):36-9. PubMed ID: 4976539
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical follow-up of a group of hypertensive patients during the year after finishing a therapeutic study with a new hypotensive drug].
    Ocon Pujadas J
    Rev Clin Esp; 1973 Feb; 128(4):331-6. PubMed ID: 4700584
    [No Abstract]   [Full Text] [Related]  

  • 9. Aliskiren: a novel renin inhibitor for hypertension.
    Parmar DM; Jadav SP
    Indian J Physiol Pharmacol; 2007; 51(1):99-101. PubMed ID: 17877301
    [No Abstract]   [Full Text] [Related]  

  • 10. Aliskiren: new drug. Arterial hypertension: no evidence of clinical efficacy.
    Prescrire Int; 2008 Apr; 17(94):47-50. PubMed ID: 18516803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
    Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
    Larochelle P; Haynes B; Maron N; Dugas S
    Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical examination of a combined antihypersensitive agent containing hydrogenated ergot alkaloid].
    Wanner J
    Schweiz Med Wochenschr; 1968 Aug; 98(32):1196-201. PubMed ID: 4974016
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trial of a new sympathoplegic hypotensive agent].
    Lebacq E; Tirzmalis A; Gossart J; Gilon L; Stenier P
    Sem Hop; 1969 Dec; 45(50):3197-202. PubMed ID: 4312510
    [No Abstract]   [Full Text] [Related]  

  • 15. Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension.
    Riccioni G; Vitulano N; D'Orazio N; Bellocci F
    Adv Ther; 2009 Jul; 26(7):700-10. PubMed ID: 19649581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aliskiren: an oral renin inhibitor for the treatment of hypertension.
    Lam S; Choy M
    Cardiol Rev; 2007; 15(6):316-23. PubMed ID: 18090068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aliskiren/hydrochlorothiazide (Tekturna HCT) for hypertension.
    Med Lett Drugs Ther; 2008 Aug; 50(1293):65-6. PubMed ID: 18719523
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value and limits of arterial pressure monitoring in the evaluation of the effectiveness of antihypertensive agents].
    Palatini P; Mos L; Guzzardi G; Martina S; Businaro R; Pessina AC
    G Clin Med; 1990 Mar; 71(3):211-9. PubMed ID: 2194881
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.
    Gradman AH; Traub D
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S22-30. PubMed ID: 17401313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardio-renal protection with aliskiren, a direct renin inhibitor, in the ASPIRE HIGHER program.
    Lee HY; Oh BH
    Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):251-7. PubMed ID: 19296761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.